In the latest trading session, 0.42 million Tharimmune Inc (NASDAQ:THAR) shares changed hands as the company’s beta touched 1.10. With the company’s most recent per share price at $1.13 changed hands at -$0.04 or -3.83% at last look, the market valuation stands at $2.38M. THAR’s current price is a discount, trading about -516.81% off its 52-week high of $6.97. The share price had its 52-week low at $1.14, which suggests the last value was -0.88% down since then. When we look at Tharimmune Inc’s average trading volume, we note the 10-day average is 0.27 million shares, with the 3-month average coming to 79.92K.

Analysts gave the Tharimmune Inc (THAR) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended THAR as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.

Tharimmune Inc (NASDAQ:THAR) trade information

Instantly THAR was in red as seen in intraday trades today. With action -16.91%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -44.33%, with the 5-day performance at -16.91% in the red. However, in the 30-day time frame, Tharimmune Inc (NASDAQ:THAR) is -25.66% down. Looking at the short shares, we see there were 30196.0 shares sold at short interest cover period of 0.5 days.

Tharimmune Inc (THAR) estimates and forecasts

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 29.89%. The 2025 estimates are for Tharimmune Inc earnings to increase by 42.15%.

Tharimmune Inc (NASDAQ:THAR)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 1.48% of Tharimmune Inc shares while 7.07% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.18%.

Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund. With 5.52 shares estimated at $6129.0 under it, the former controlled 0.26% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.06% of the shares, roughly 1.35 shares worth around $1498.0.